Companies

NovoCure Ltd (NVCR) SEC filings

CIK 0001645113 · Surgical & Medical Instruments & Apparatus (SIC 3841) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)605.2 M537.8 M535.0 M
Net income (USD)19.8 M
Diluted EPS (USD/shares)-1.56-0.88-0.56

Latest filings

FiledFormDescriptionPeriod
2026-10-018-K8-K items 7.01,9.012026-10-01
2026-09-098-K8-K items 5.02,9.012026-09-02
2026-09-018-K8-K items 8.01,9.012026-09-01
2026-07-23144144
2026-07-238-K8-K items 2.02,9.012026-07-23
2026-07-2310-Q10-Q2026-06-30
2026-07-014PRIMARY DOCUMENT2026-06-30
2026-07-014PRIMARY DOCUMENT2026-06-30
2026-07-014PRIMARY DOCUMENT2026-06-30
2026-07-014PRIMARY DOCUMENT2026-06-30
2026-06-308-K8-K items 7.01,9.012026-06-30
2026-06-188-K8-K items 7.01,9.012026-06-18
2026-06-058-K8-K items 5.02,5.07,9.012026-06-03
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-054PRIMARY DOCUMENT2026-06-03
2026-06-054PRIMARY DOCUMENT2026-06-03
2026-06-054PRIMARY DOCUMENT2026-06-03
2026-06-054PRIMARY DOCUMENT2026-06-03
2026-06-054PRIMARY DOCUMENT2026-06-03
2026-06-054PRIMARY DOCUMENT2026-06-03
2026-06-054PRIMARY DOCUMENT2026-06-03
2026-06-054PRIMARY DOCUMENT2026-06-03
2026-06-04144144
2026-06-034PRIMARY DOCUMENT2026-06-02
2026-06-034PRIMARY DOCUMENT2026-06-02

Forms on file (last 1,000): 4 646, 8-K 123, SC 13G/A 40, 144 37, 10-Q 28, 3 19, S-8 POS 16, DEFA14A 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=NVCR (0.002 USD), /gw/filings/filings?ticker=NVCR&form=8-K, /gw/filings/facts?ticker=NVCR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange